Neximmune to present at the morgan stanley 19th annual global healthcare conference

Gaithersburg, md., sept. 10, 2021 (globe newswire) -- neximmune, inc. (nasdaq: nexi), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific t cells, today announced that scott carmer, chief executive officer, will participate in a fireside chat during the morgan stanley 19th annual global healthcare conference today, september 10, 2021 at 1:15p.m. eastern time.
NEXI Ratings Summary
NEXI Quant Ranking